Ocugen, Inc. is a late-stage biotechnology company developing gene therapies for blindness and retinal diseases. Its novel modifier gene therapy platform includes OCU400 for retinitis pigmentosa, OCU410ST for Stargardt disease, and OCU410 for geographic atrophy secondary to dry AMD. The company also develops OCU200, a biologic for DME/DR/wet AMD, NeoCart for knee cartilage repair, and an inhaled mucosal vaccine platform including OCU500 (COVID-19) and influenza candidates.
expected 2026-12-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-04 | 2025-12-31 | 0001628280-26-014435 | EDGAR | 102K words |
| 2025-03-05 | 2024-12-31 | 0001628280-25-010271 | EDGAR | 100K words |
| 2024-04-16 | 2023-12-31 | 0001628280-24-016378 | EDGAR | 102K words |
| 2023-02-28 | 2022-12-31 | 0001628280-23-005382 | EDGAR | 100K words |
| 2022-02-28 | 2021-12-31 | 0001628280-22-004085 | EDGAR | — |
| 2021-03-19 | 2020-12-31 | 0001628280-21-005124 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001628280-20-004221 | EDGAR | — |
| 2019-03-22 | 2018-12-31 | 0001564590-19-008830 | EDGAR | — |
| 2018-03-15 | 2017-12-31 | 0001564590-18-005711 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001193125-17-085372 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-054057 | EDGAR | 24K words |
| 2025-11-05 | 2025-09-30 | 0001372299-25-000013 | EDGAR | 24K words |
| 2025-08-04 | 2025-06-30 | 0001628280-25-037310 | EDGAR | 24K words |
| 2025-05-09 | 2025-03-31 | 0001628280-25-024093 | EDGAR | 21K words |
| 2024-11-14 | 2024-09-30 | 0001628280-24-047846 | EDGAR | 21K words |
| 2024-08-08 | 2024-06-30 | 0001628280-24-035822 | EDGAR | 19K words |
| 2024-05-14 | 2024-03-31 | 0001628280-24-023038 | EDGAR | 17K words |
| 2023-11-09 | 2023-09-30 | 0001628280-23-038008 | EDGAR | 21K words |
| 2023-08-21 | 2023-06-30 | 0001628280-23-030128 | EDGAR | 19K words |
| 2023-05-05 | 2023-03-31 | 0001628280-23-016011 | EDGAR | 18K words |
| 2022-11-08 | 2022-09-30 | 0001628280-22-028775 | EDGAR | — |
| 2022-08-05 | 2022-06-30 | 0001628280-22-021255 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-23 | 0001628280-26-063084 | EDGAR | 1K words |
| 2026-09-08 | 0001104659-26-105968 | EDGAR | 3K words |
| 2026-08-06 | 0001104659-26-091691 | EDGAR | 3K words |
| 2026-07-13 | 0001104659-26-082897 | EDGAR | 1K words |
| 2026-03-27 | 0001628280-26-021541 | EDGAR | 4K words |
| 2026-03-24 | 0001104659-26-033724 | EDGAR | 4K words |
| 2026-03-20 | 0001104659-26-032442 | EDGAR | 1K words |
| 2026-03-04 | 0001104659-26-023290 | EDGAR | 5K words |
| 2026-03-04 | 0001104659-26-023288 | EDGAR | 3K words |
| 2026-02-09 | 0001104659-26-011765 | EDGAR | 5K words |
364 total filings indexed. 332 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001372299 |
| Ticker | OCGN |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.ocugen.com |
| Listed | 2014-12-03 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/OCGN (~200 tokens, structured JSON with cryptographic provenance)